

New research facility opens in Mesa | News | themesatribune.com
As the COVID-19 pandemic becomes a page in the history books, Centricity Research looks to the future in the East Valley.
Read the full article hereAs the COVID-19 pandemic becomes a page in the history books, Centricity Research looks to the future in the East Valley.
Read the full article hereCentricity Research has announced the merger with Aventiv Research to expand its footprint and expertise across the US and Canada.
Read the full article hereNorth America's Largest lntegrated Research Site Organization, Centricity Research, Expands Further with Addition of Aventiv Research - read this article along with other careers information, tips and advice on BioSpace
Read the full article hereNorth America's clinical research leader, Centricity Research, announced that Aventiv Research has merged with the organization, extending the...
Read the full article hereExperienced physician and clinician brings proven expertise, improving quality metrics and driving efficiencies for Aventiv Research.
Read the full article hereThe Site Patient Recruitment Innovation Award (SPRIA) recognizes sites that employ innovative strategies to achieve enrollment success.
Read the full article hereNow that anyone over the age of 12 is eligible to get a COVID-19 vaccine, attention has turned to when younger children might be able to get the shot.
Read the full article hereEnrollment begins for Pfizer-BioNtech clinical trial to evaluate its BNT162b2 COVID-19 vaccine in children aged 6 months to 11 years and Novavax clinical trial to assess NVX-CoV2373 for the prevention of COVID-19 in 12-17-year-old adolescents.
Read the full article hereColumbus-based clinical research company collaborates with super network to advance the efficiency of its clinical trials and expand expertise across vaccine, internal medicine, dermatology, and many additional therapeutic areas.
Read the full article hereSenior Lecturer Suzanne Newcomb stepped away from her piano last summer to roll up her sleeve and participate in a Pfizer vaccine study.
Read the full article hereMeet three Central Ohioans who participated in the Pfizer COVID-19 vaccine study at Aventiv Research.
Read the full article hereThe decision represents the conclusion of a complex and public kabuki dance between the companies and regulators.
Read the full article hereAventiv Research is enrolling healthy volunteers ages 12-15 in the Columbus area for the trial.
Read the full article hereMajor news in the effort to treat patients with COVID-19. A Columbus based medical research company is spearheading a potential medication.
Read the full article hereAventiv Research is conducting a new COVID-19 clinical trial in Columbus, Ohio, and unlike some of the vaccine trials that have recently been announced, this test requires volunteers who have already tested positive for the virus.
Read the full article hereBLAZE-1 Study is evaluating a potential COVID-19 antibody treatment following successful laboratory studies.
Read the full article hereThe race to find a vaccine that will help prevent COVID-19 is reaching the final stages of research in the United States, and a local man is among those volunteering to be injected with the investigative drug at Aventiv Research.
Read the full article herePfizer vaccine candidate being tested at Aventiv Research in Columbus.
Read the full article hereDr. Samir Arora, President & Medical Director will lead the Aventiv Research study program.
Read the full article hereSeasoned Financial Executive Jeff Bruner Joins Aventiv Research.
Read the full article here20-year business development veteran will drive Aventiv's continued growth in the early pharmaceutical sciences market.
Read the full article hereAventiv Research Women's Health will offer clinical studies designed to bring medical advancements and opportunities to women in Central Ohio in key therapeutic areas.
Read the full article here